Literature DB >> 7223426

Clinical and morphological findings in two cases of bromocriptine-treated prolactinomas.

M Anniko, J Wersäll.   

Abstract

The morphology of two cases of prolactin (PRL) secreting pituitary tumours was analyzed at the light and electron microscopic level. Prior to surgery both patients had been treated with bromocriptine. In both tumors, groups of cells revealed considerable morphological changes but these were not confined to the whole adenoma. In fact, most cells still appeared ultrastructurally intact. Pieces from both adenomas were explanted to an in vitro system. These specimens secreted mainly PRL though smaller amounts of growth hormone (GH) were also produced. The cell morphology of the cultured specimens often showed a large number of preserved cells.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7223426     DOI: 10.1111/j.1699-0463.1981.tb00185.x

Source DB:  PubMed          Journal:  Acta Pathol Microbiol Scand A        ISSN: 0365-4184


  4 in total

1.  Rapid re-expansion of a macroprolactinoma after early discontinuation of bromocriptine.

Authors:  J J Orrego; W F Chandler; A L Barkan
Journal:  Pituitary       Date:  2000-11       Impact factor: 4.107

2.  Morphologic effects of bromocriptine on spontaneously occurring pituitary prolactin-cell hyperplasia in old Long-Evans rats.

Authors:  D J McComb; P Hellmann; M O Thorner; D Scott; W S Evans; K Kovacs
Journal:  Am J Pathol       Date:  1986-01       Impact factor: 4.307

3.  Oestrogen and testosterone effects on hormone secretion and cell morphology of human pituitary tumours.

Authors:  M Anniko; S Werner; P Eneroth
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1983

4.  Effects of pergolide on diethylstilbestrol-induced rat pituitary hyperplasia.

Authors:  R V Lloyd; K Schmidt; V Nath
Journal:  Am J Pathol       Date:  1985-12       Impact factor: 4.307

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.